Technical Analysis for NMRD - Nemaura Medical Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 1.58 | -4.24% | -0.07 |
Earnings due: Feb 9
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Volume Surge | Other | 0.00% | |
Calm After Storm | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Fell Below 20 DMA | Bearish | -4.24% | |
Fell Below 200 DMA | Bearish | -4.24% | |
Fell Below 50 DMA | Bearish | -4.24% | |
Slingshot Bullish | Bullish Swing Setup | -4.24% | |
Volume Surge | Other | -4.24% | |
Upper Bollinger Band Walk | Strength | -4.24% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
50 DMA Resistance | 4 days ago |
Gapped Down (Full) | 4 days ago |
20 DMA Resistance | 4 days ago |
2x Volume Pace | 4 days ago |
1.5x Volume Pace | 4 days ago |
Get a Trading Assistant
- Earnings date: 02/09/2023
Nemaura Medical Inc. Description
Nemaura Medical, Inc. is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company's focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source. CGM through a non-invasive patch can enable early detection of subtle changes in blood glucose levels. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a CGM, named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes, and may also be used to screen pre-diabetic patients. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Diabetes Medical Device Glucose Blood Test Endocrine System Wireless Devices Diabetes Mellitus Medical Monitoring Blood Glucose Monitoring Endocrinology I Diabetes Ii Diabetes Blood Sugar Level Continuous Glucose Monitor
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.576 |
52 Week Low | 1.5 |
Average Volume | 118,062 |
200-Day Moving Average | 2.34 |
50-Day Moving Average | 1.98 |
20-Day Moving Average | 1.92 |
10-Day Moving Average | 2.05 |
Average True Range | 0.35 |
RSI | 41.52 |
ADX | 23.96 |
+DI | 28.29 |
-DI | 28.81 |
Chandelier Exit (Long, 3 ATRs) | 2.38 |
Chandelier Exit (Short, 3 ATRs) | 2.56 |
Upper Bollinger Bands | 2.59 |
Lower Bollinger Band | 1.26 |
Percent B (%b) | 0.24 |
BandWidth | 69.15 |
MACD Line | 0.03 |
MACD Signal Line | 0.02 |
MACD Histogram | 0.0088 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.87 | ||||
Resistance 3 (R3) | 1.87 | 1.79 | 1.82 | ||
Resistance 2 (R2) | 1.79 | 1.71 | 1.78 | 1.80 | |
Resistance 1 (R1) | 1.68 | 1.67 | 1.64 | 1.68 | 1.79 |
Pivot Point | 1.60 | 1.60 | 1.58 | 1.59 | 1.60 |
Support 1 (S1) | 1.49 | 1.52 | 1.45 | 1.48 | 1.37 |
Support 2 (S2) | 1.41 | 1.48 | 1.40 | 1.36 | |
Support 3 (S3) | 1.30 | 1.41 | 1.34 | ||
Support 4 (S4) | 1.29 |